Mechanism of Action

Research indicates that MOTS-c is associated with activation of AMP-activated protein kinase (AMPK), a central cellular energy sensor, and with the regulation of metabolic homeostasis in cultured cells and animal models. Mechanistic studies suggest that MOTS-c influences the folate–methionine one-carbon cycle: under metabolic stress it is reported to modulate 5-methyltetrahydrofolate levels, leading to accumulation of the AMPK-activating intermediate AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), which studies propose as an upstream link to observed AMPK activation. Reported downstream effects in these models include shifts in glucose metabolism and insulin-sensitivity markers.

Subsequent research suggests that MOTS-c can dynamically translocate from the cytoplasm to the nucleus in response to metabolic stressors such as glucose restriction, where studies indicate it participates in the regulation of nuclear gene expression in an AMPK-dependent manner. In this context, investigators have reported associations with stress-responsive and antioxidant-response-element (ARE) transcriptional programs, including interaction with transcription factors such as NFE2L2/NRF2. Additional preclinical work characterizes MOTS-c as an exercise-responsive peptide detectable in skeletal muscle and circulation. These pathways are described as research-identified and mechanistic; they do not constitute established or approved therapeutic actions.

Research Applications

• → In the foundational 2015 study, MOTS-c was reported to promote AMPK activation and to influence metabolic homeostasis in cell and rodent models, with observations of reduced diet-induced weight gain and insulin resistance in mice.
• → Mechanistic research links MOTS-c to the folate–AICAR–AMPK axis, proposing modulation of the one-carbon/folate cycle as an upstream driver of the observed AMPK activation.
• → A 2018 study reported that MOTS-c translocates to the nucleus under metabolic stress and regulates stress-responsive nuclear gene expression, including antioxidant-response-element pathways and NRF2 interaction, in an AMPK-dependent manner.
• → Preclinical work characterizes MOTS-c as an exercise-induced, mitochondrial-encoded peptide whose expression in skeletal muscle and circulation increased with exercise in the studied models.
• → In aged-mouse models, intermittent MOTS-c administration was associated with changes in physical-capacity and muscle-homeostasis endpoints, findings that remain preclinical and not established in humans.

Analytical Validation

MOTS-C is verified via LC-MS and HPLC analysis. Each lot is tested for identity, purity (≥99% target), and endotoxin levels. Full certificate of analysis is available upon request.